These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35107425)

  • 41. Comparing Peripheral Blood Mononuclear Cell DNA and Circulating Plasma viral RNA pol Genotypes of Subtype C HIV-1.
    Banks L; Gholamin S; White E; Zijenah L; Katzenstein DA
    J AIDS Clin Res; 2012 Feb; 3(2):141-147. PubMed ID: 23019537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and evaluation of a speech-generating AAC mobile app for minimally verbal children with autism spectrum disorder in Mainland China.
    An S; Feng X; Dai Y; Bo H; Wang X; Li M; Woo JZ; Liang X; Guo C; Liu CX; Wei L
    Mol Autism; 2017; 8():52. PubMed ID: 29026509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Digital Marshmallow Test (DMT) Diagnostic and Monitoring Mobile Health App for Impulsive Behavior: Development and Validation Study.
    Sobolev M; Vitale R; Wen H; Kizer J; Leeman R; Pollak JP; Baumel A; Vadhan NP; Estrin D; Muench F
    JMIR Mhealth Uhealth; 2021 Jan; 9(1):e25018. PubMed ID: 33480854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DiaFit: The Development of a Smart App for Patients with Type 2 Diabetes and Obesity.
    Modave F; Bian J; Rosenberg E; Mendoza T; Liang Z; Bhosale R; Maeztu C; Rodriguez C; Cardel MI
    JMIR Diabetes; 2016; 1(2):. PubMed ID: 29388609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
    Arora SK; Gupta S; Toor JS; Singla A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience.
    Mazzuti L; Melengu T; Falasca F; Calabretto M; Cella E; Ciccozzi M; Mezzaroma I; Iaiani G; Spaziante M; d'Ettorre G; Fimiani C; Vullo V; Antonelli G; Turriziani O
    J Glob Antimicrob Resist; 2020 Mar; 20():298-303. PubMed ID: 31518723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance-associated mutations in HIV-1 among patients failing first-line antiretroviral therapy.
    Saini S; Bhalla P; Gautam H; Baveja UK; Pasha ST; Dewan R
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):203-9. PubMed ID: 21990611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
    Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M
    Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.
    Rhee SY; Blanco JL; Jordan MR; Taylor J; Lemey P; Varghese V; Hamers RL; Bertagnolio S; Rinke de Wit TF; Aghokeng AF; Albert J; Avi R; Avila-Rios S; Bessong PO; Brooks JI; Boucher CA; Brumme ZL; Busch MP; Bussmann H; Chaix ML; Chin BS; D'Aquin TT; De Gascun CF; Derache A; Descamps D; Deshpande AK; Djoko CF; Eshleman SH; Fleury H; Frange P; Fujisaki S; Harrigan PR; Hattori J; Holguin A; Hunt GM; Ichimura H; Kaleebu P; Katzenstein D; Kiertiburanakul S; Kim JH; Kim SS; Li Y; Lutsar I; Morris L; Ndembi N; Ng KP; Paranjape RS; Peeters M; Poljak M; Price MA; Ragonnet-Cronin ML; Reyes-Terán G; Rolland M; Sirivichayakul S; Smith DM; Soares MA; Soriano VV; Ssemwanga D; Stanojevic M; Stefani MA; Sugiura W; Sungkanuparph S; Tanuri A; Tee KK; Truong HM; van de Vijver DA; Vidal N; Yang C; Yang R; Yebra G; Ioannidis JP; Vandamme AM; Shafer RW
    PLoS Med; 2015 Apr; 12(4):e1001810. PubMed ID: 25849352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
    Yalçınkaya T; Köse S
    Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the Far Side of Mobile Health: Information Security and Privacy of Mobile Health Apps on iOS and Android.
    Dehling T; Gao F; Schneider S; Sunyaev A
    JMIR Mhealth Uhealth; 2015 Jan; 3(1):e8. PubMed ID: 25599627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical applications: a database and characterization of apps in Apple iOS and Android platforms.
    Seabrook HJ; Stromer JN; Shevkenek C; Bharwani A; de Grood J; Ghali WA
    BMC Res Notes; 2014 Aug; 7():573. PubMed ID: 25167765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation of an mHealth App to Promote Engagement During HIV Care and Viral Load Suppression in Johannesburg, South Africa (iThemba Life): Pilot Technical Feasibility and Acceptability Study.
    Lalla-Edward ST; Mashabane N; Stewart-Isherwood L; Scott L; Fyvie K; Duncan D; Haile B; Chugh K; Zhou Y; Reimers J; Pan M; Venkatraman M; Stevens W
    JMIR Form Res; 2022 Feb; 6(2):e26033. PubMed ID: 35107427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients.
    Birk M; Sönnerborg A
    AIDS; 1998 Dec; 12(18):2369-75. PubMed ID: 9875574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of Drug Resistance Mutations in Protease, Reverse Transcriptase, and Integrase Genes of North Central Mexico HIV Isolates.
    Hernandez-Sanchez PG; Guerra-Palomares SE; Ramirez-GarciaLuna JL; Arguello JR; Noyola DE; Garcia-Sepulveda CA
    AIDS Res Hum Retroviruses; 2018 Jun; 34(6):498-506. PubMed ID: 29620931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
    Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A data encryption solution for mobile health apps in cooperation environments.
    Silva BM; Rodrigues JJ; Canelo F; Lopes IC; Zhou L
    J Med Internet Res; 2013 Apr; 15(4):e66. PubMed ID: 23624056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating Chinese Mobile Health Apps for Ankylosing Spondylitis Management: Systematic App Search.
    Song Y; Chen H
    JMIR Mhealth Uhealth; 2021 Jul; 9(7):e27234. PubMed ID: 34259644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study.
    Ait-Khaled M; Rakik A; Griffin P; Stone C; Richards N; Thomas D; Falloon J; Tisdale M;
    Antivir Ther; 2003 Apr; 8(2):111-20. PubMed ID: 12741623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.